Benefit Profile of Recombinant Human Soluble Thrombomodulin in Sepsis-Induced DIC

Critical Care - United Kingdom
doi 10.1186/cc13433
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Combination Effect of Antithrombin and Recombinant Human Soluble Thrombomodulin in a Lipopolysaccharide Induced Rat Sepsis Model

Critical Care
Critical CareIntensive Care Medicine
2009English

Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy

JAMA - Journal of the American Medical Association
Medicine
2019English

Drug-Induced Thrombotic Thrombocytopenic Purpura Successfully Treated With Recombinant Human Soluble Thrombomodulin

Internal Medicine
Internal MedicineMedicine
2013English

Phase I Study of Solulin, a Novel Recombinant Soluble Human Thrombomodulin Analogue

Thrombosis and Haemostasis
Hematology
2011English

Enhanced Effect of Recombinant Human Soluble Thrombomodulin by Ultrasound Irradiation in Acute Liver Failure

Scientific Reports
Multidisciplinary
2020English

Clinical Outcomes of Recombinant Human-Soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors

Anticancer Research
MedicineCancer ResearchOncology
2019English

Septic Disseminated Intravascular Coagulation (DIC) and Thrombomodulin

Journal of the Japanese Society of Intensive Care Medicine
2014English

Human Soluble Recombinant Thrombomodulin, ART-123, Resolved Early Phase Coagulopathies, but Did Not Significantly Alter the 28 Day Outcome in the Treatment of DIC Associated With Infectious Systemic Inflammatory Response Syndromes

Journal of Clinical Medicine
2019English

Soluble Variants of Human Recombinant Glutaminyl Cyclase

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy